Droxidopa Therapy
Droxidopa Therapy is a pharmacological intervention involving the administration of droxidopa, a prodrug of norepinephrine, to ameliorate neurogenic orthostatic hypotension by augmenting sympathetic vasoconstrictor tone.
32
Publications
1.7K
Citations
104
Authors
52
Institutions
Publications per year
2017–2026
8
Parents
32
Droxidopa for neurogenic orthostatic hypotension
Horacio Kaufmann, Roy Freeman, Italo Biaggioni et al. · Neurology · 2014 · 279 citations · Full text
Robert A. Hauser, Stuart Isaacson, Jerome Lisk et al. · Movement Disorders · 2014 · 149 citations · Full text
Christopher J. Mathias, Jean‐Michel Sénard, Stefan Braune et al. · Clinical Autonomic Research · 2001 · 116 citations
Medicine, Neurology, Pharmacology +17
1–5 of 32
104
9
h-index
7
h-index
7
h-index
Parkinson's Research and Education Foundation, United States
6 publications · 390 citations
6
h-index
5
h-index
1–5 of 104
52
Lundbeck (United States)
Deerfield, United States
10 h-index
24 publications
1.7K citations
Vanderbilt University Medical Center
Nashville, United States
6 h-index
21 publications
3.5K citations
Deerfield (United States)
New York, United States
5 h-index
12 publications
514 citations
Parkinson's Research and Education Foundation
Boca Raton, United States
5 h-index
9 publications
632 citations
Southwestern Medical Center
Lawton, United States
3 h-index
3 publications
89 citations
New York University
New York, United States
3 h-index
6 publications
433 citations

Imperial College London
London, United Kingdom
3 h-index
13 publications
3.1K citations
The University of Texas Southwestern Medical Center
Dallas, United States
3 h-index
3 publications
89 citations
1–8 of 52
3 publications · 175 citations
3
h-index
JASH · 2 publications · 52 citations
2
h-index
2 publications · 314 citations
2
h-index
2 publications · 139 citations
2
h-index
MDCP · 2 publications · 35 citations
2
h-index
1–5